X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA Foundation recognizes inaugural Challenge Award recipients

By Eileen Cannon  |    October 6, 2017
Last month, the PhRMA Foundation announced the recipients of the inaugural Challenge Awards at Morning Consult. These awards recognize the best and the brightest that are identifying...   Read More

The journey to better health care requires a holistic view

By Guest Contributor  |    September 18, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Modernizing FDA regulations to advance a value-driven health care system

By Michelle Drozd  |    June 8, 2017
A modern regulatory framework is the foundation of an innovative health care system that allows stakeholders to work together to deliver better outcomes for patients. To advance critical...   Read More

ICYMI: Avalere and FasterCures develop new value framework from patient perspective

By Holly Campbell  |    May 31, 2017
In case you missed it, a year-long collaboration between Avalere and FasterCures has resulted in the first value framework from the patient perspective. Unlike other frameworks which include...   Read More

RA medicines often demonstrate far greater benefits to patients than initially understood

By Lauren Neves  |    April 5, 2017
In the last decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients’ treatment options and significantly improved outcomes,...   Read More

New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price

By Holly Campbell  |    March 29, 2017
More than half of commercially insured patients’ out-of-pocket spending for brand medicines is based on full list prices, according to a new analysis from Amundsen Consulting, a division of...   Read More

Stakeholders Agree: Modernize the legal framework to support move to value-driven health care

By Michelle Drozd  |    March 6, 2017
Modernizing certain laws and regulations to support the move to value-driven health care is an important step in moving our health care system forward. As part of PhRMA’s proactive policy...   Read More

How do multiple sclerosis patients define value?

By Lauren Neves  |    February 24, 2017
There are crucial conversations occurring in the health care system about how value is defined. To explore how multiple sclerosis (MS) patients, providers and payers view value, Real Endpoints...   Read More

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

By Holly Campbell  |    February 9, 2017
Following the biopharmaceutical industry’s recent meeting with President  Donald J. Trump, PhRMA president and CEO Stephen J. Ubl joined Dan Diamond on POLITICO’s Pulse Check podcast to discuss...   Read More

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

By Holly Campbell  |    February 6, 2017
PhRMA president and CEO Stephen J. Ubl recently spoke with FOX Business anchor Neil Cavuto on his personal connection to the value of medical technology with his son’s type 1 diabetes diagnosis,...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates